DEA plan to stem supply of prescription drugs draws skepticism
A new proposal aims to empower the DEA to more aggressively limit manufacturing levels and to put hundreds of drug makers on notice.
WASHINGTON — With pressure building on the the Drug Enforcement Administration to stem the supply of prescription drugs, a new proposal aims to empower the agency to more aggressively limit manufacturing levels and to put hundreds of drug makers on notice.
It’s not yet clear whether the proposal will achieve either goal.
According to a rule introduced last week, the DEA would be able to tighten overall quotas and individual
